V

Verastem

D
VSTM
USD
0.105
(3.8674%)
Market Closed
29,267.00
Volume
-2.92
EPS
-
Div Yield
-0.878505
P/E
113,487,360.90
Market Cap
Today
3.8674%
1 Week
1.989%
1 Month
12.800%
6 Months
-75.088%
12 Months
-70.316%
Year To Date
-65.356%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

BYD's Rapid Rise Has Tesla in A Spin

30.05.2024
Stocks news

Utilities Surge Amid AI Boom

16.05.2024
Stocks news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Tesla Sales Drop Amid Intensifying EV Competition

03.04.2024
Stocks news
More
Related Instruments
G
GERN
0.22
(4.878%)
USD
S
SNDX
0.61
(3.387%)
USD
C
CRSP
-0.11
(-0.2219%)
USD
S
SGMO
0.0617
(7.3584%)
USD
B
BCEL
(%)
USD
F
FATE
0.12
(3.0928%)
USD
C
CRSP
-0.11
(-0.2219%)
USD
N
NVCR
0.23
(1.3061%)
USD
C
CLLS
0.04
(1.7544%)
USD
B
BLUE
-0.0046
(-0.9287%)
USD
X
XLRN
(%)
USD

Title:
Verastem

Sector:
Healthcare
Industry:
Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Do you need help or have a question?
Contact Us